Literature DB >> 32100324

Off-label use of quetiapine in nursing homes: Does medical specialty of prescribing physicians play a role?

Laura Müller1, Roberta Noseda1, Raffaela Bertoli1, Marco Bissig2, Alessandro Ceschi1,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32100324      PMCID： PMC7318997          DOI： 10.1111/bcp.14232

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Off-label use of atypical antipsychotics: cause for concern?

Authors:  Andrew McKean; Erik Monasterio
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

2.  Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Authors:  Lon S Schneider; Pierre N Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; T Scott Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

3.  Indications of atypical antipsychotics in the elderly.

Authors:  Andrew McKean; Erik Monasterio
Journal:  Expert Rev Clin Pharmacol       Date:  2014-10-29       Impact factor: 5.045

4.  Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Authors:  Clive Ballard; Marisa Margallo-Lana; Edmund Juszczak; Simon Douglas; Alan Swann; Alan Thomas; John O'Brien; Anna Everratt; Stuart Sadler; Clare Maddison; Lesley Lee; Carol Bannister; Ruth Elvish; Robin Jacoby
Journal:  BMJ       Date:  2005-02-18

5.  Drug, patient, and physician characteristics associated with off-label prescribing in primary care.

Authors:  Tewodros Eguale; David L Buckeridge; Nancy E Winslade; Andrea Benedetti; James A Hanley; Robyn Tamblyn
Journal:  Arch Intern Med       Date:  2012-05-28

6.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

Review 7.  Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.

Authors:  H Karl Greenblatt; David J Greenblatt
Journal:  J Clin Pharmacol       Date:  2016-04-29       Impact factor: 3.126

Review 8.  Quetiapine safety in older adults: a systematic literature review.

Authors:  N El-Saifi; W Moyle; C Jones; H Tuffaha
Journal:  J Clin Pharm Ther       Date:  2016-02       Impact factor: 2.512

9.  Prescribing of antipsychotics in UK primary care: a cohort study.

Authors:  Louise Marston; Irwin Nazareth; Irene Petersen; Kate Walters; David P J Osborn
Journal:  BMJ Open       Date:  2014-12-18       Impact factor: 2.692

10.  Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany.

Authors:  Caroline Lücke; Jürgen M Gschossmann; Teja W Grömer; Sebastian Moeller; Charlotte E Schneider; Aikaterini Zikidi; Alexandra Philipsen; Helge H O Müller
Journal:  Ann Gen Psychiatry       Date:  2018-02-08       Impact factor: 3.455
  10 in total
  2 in total

1.  The Problem With Maslow's Hammer.

Authors:  William M McDonald
Journal:  Am J Geriatr Psychiatry       Date:  2022-06-12       Impact factor: 7.996

2.  Who prescribes quetiapine in Denmark?

Authors:  Mikkel Højlund; Lotte Rasmussen; Morten Olesen; Trine Munk-Olsen; Anton Pottegård
Journal:  Br J Clin Pharmacol       Date:  2022-05-19       Impact factor: 3.716
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.